• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Evgen Pharma recruits over 100 patients into COVID-19 trial pharmatimes
    February 19, 2021
    UK-based Evgen Pharma has announced that it has now recruited a total of 102 patients into a trial investigating its lead asset SFX-01 in COVID-19.
  • Evgen scores full approval for COVID-19 trial launch pharmatimes
    October 28, 2020
    Evgen Pharma has received full regulatory approval for its STAR trial, which will investigate the company’s lead asset to treat acute respiratory distress syndrome (ARDS) in patients with suspected COVID-19.
  • Evgen's SFX-01 selected for COVID-19 trial pharmatimes
    June 18, 2020
    Evgen Pharma's lead candidate SFX-01 has been selected for evaluation in a randomised Phase II/III trial, to be sponsored by the University of Dundee, which aims to investigate its potential as a treatment for COVID-19.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service